Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine
Reference42 articles.
1. European Society of Cardiology Guidelines. Guidelines for the diagnosis and treatment of acute and chronic heart failure [online]. Available from URL: http://eurheartj.oxfordjournals.org/content/early/2012/05/17/eurheartj.ehs104.full.pdf+html [Accessed 2012 Nov 9]
2. Swedberg K, Komajda M, Bohm M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. [Erratum appears in Lancet 2010 Dec 11; 376 (9757): 1988 Note: Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M]]. Lancet 2010 Sep 11; 376(9744): 875–85
3. National Institute for Health and Clinical Excellence. Chronic heart failure: management of chronic heart failure in adults in primary and secondary care [online]. Available from URL: http://publications.nice.org.uk/chronic-heart-failure-CG108 [Accessed 2012 Nov 9]
4. Ma Y, Chilton RJ, Lindsey ML. Heart rate reduction: an old and novel candidate heart failure therapy. Hypertension 2012 May; 59(5): 908–10
5. Mulder P, Barbier S, Chagraoui A, et al. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 2004 Apr 6; 109(13): 1674–9
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献